Remark Pharma Private Limited - Company Profile

It is a pharma private limited company based in Ranchi, Jharkhand, India, established in 2011.
2011 Ranchi, Jharkhand, India Active
Last Updated:
Access Report
About Remark Pharma Private Limited

Remark Pharma Private Limited, a active private limited company, was established on 06 June 2011 in Ranchi, Jharkhand, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24231JH2011PTC014896. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.18 M.

It upholds a compliant status. Its leadership includes Pawan Kumar Arya (Director), Sangeeta Gupta (Director), Kanchan Arya (Director). Past directors included Kamal Bhushan. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sri Bishwanath Bhawan, Mo- Madhukam, P.O.: Hehal, P.S.: Sukhdeonagar,, Ranchi, Jharkhand, 834005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231JH2011PTC014896

  • Registration Number

    014896

  • Incorporation Date

    06 June 2011

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.18 M

  • ROC Code

    Roc Ranchi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.18 M
  • Company Age 14 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 2.50%
  • Profit Growth **** -165.94%
  • Ebitda **** 523.63%
  • Net Worth -2.63%
  • Total Assets **** 4.25%
Company report

Remark Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Remark Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Remark Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Pawan Kumar Arya Director 11 May 2016 Current
Sangeeta Gupta Director 11 May 2016 Current
Kanchan Arya Director 06 Jun 2011 Current
Deepak Kumar Director 06 Jun 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 May 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Remark Pharma.

Remark Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.5% increase. The company also saw a substantial fall in profitability, with a 165.94% decrease in profit. The company's net worth dipped by a decrease of 2.63%.

Remark Pharma revenue growth over time
Remark Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.50%
*******
*******
*******
*******
Revenue from Operations
*******
 4.54%
*******
*******
*******
*******
Total Assets
*******
 4.25%
*******
*******
*******
*******
Profit or Loss
*******
 -165.94%
*******
*******
*******
*******
Net Worth
*******
 -2.63%
*******
*******
*******
*******
EBITDA
*******
 523.63%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Remark Pharma?

In 2019, Remark Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Remark Pharma?

Unlock and access historical data on people associated with Remark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Remark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Remark Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Remark Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Remark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Remark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi. was documented.

  • Director Appointment

    The activity Pawan Kumar Arya was appointed as a Director was appointed as a Director on 11 May 2016 & has been associated with this company since 9 years 9 months . was completed.

  • Director Appointment

    The activity Sangeeta Gupta was appointed as a Director was appointed as a Director on 11 May 2016 & has been associated with this company since 9 years 9 months . was completed.

  • Director Appointment

    The activity Kanchan Arya was appointed as a Director was appointed as a Director on 06 Jun 2011 & has been associated with this company since 14 years 8 months . was completed.

  • Director Appointment

    Deepak Kumar was appointed as a Director was appointed as a Director on 06 Jun 2011 & has been associated with this company since 14 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Remark Pharma Private Limited?

The CIN of Remark Pharma Private Limited is U24231JH2011PTC014896.

Where is Remark Pharma Private Limited headquartered?

Remark Pharma Private Limited is headquartered at Sri Bishwanath Bhawan, Mo- Madhukam, P.O.: Hehal, P.S.: Sukhdeonagar,, Ranchi, Jharkhand, 834005.

When was Remark Pharma Private Limited incorporated?

Remark Pharma Private Limited was incorporated on 06 June 2011.

Who are the current directors of Remark Pharma Private Limited?

The current directors of Remark Pharma Private Limited are

What is the primary industry of Remark Pharma Private Limited?

The primary industry of Remark Pharma Private Limited is Pharma.

Is Remark Pharma Private Limited a listed company?

Remark Pharma Private Limited is unlisted.

What is the capital structure of Remark Pharma Private Limited?

The authorized capital of Remark Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.18 M.

What is the compliance status of Remark Pharma Private Limited?

The compliance status of Remark Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available